Money and medicine: Challenges and opportunities for science writers
- Time:
- Monday, October 12th, 8:30 am to 9:30 am
- Location:
- MIT Kresge Auditorium
- Speaker(s):
- Katrine BosleyChief executive officer, Editas Medicine
- William N. HaitGlobal head, research and development, Janssen Research & Development, Johnson & Johnson
- David SchenkeinChief executive officer, Agios Pharmaceuticals
- Meg TirrellReporter, CNBC
- Moderator(s):
- Ron WinslowDeputy editor, health and science, and senior medical and health care writer, Wall Street Journal
Science writers are comfortable covering the most complex and arcane topics, but when it comes to corporate science they often don't engage. Yet amid a flurry of advances in biology, a major story today is how discovery is translated into new medicines — the province of entrepreneurs, venture capitalists and pharmaceutical companies. This Science + Science Writing panel will draw on the resources of the Boston and Cambridge academic/biotech industry complex to give researchers, entrepreneurs and science writers a glimpse of the kind of translational science being done outside academia and a forum to discuss the challenges and opportunities of reporting at the intersection of innovation and commerce. Social media hashtag: #BiotechStories.